Search details
1.
Barriers to a successful healthcare transition for individuals with urea cycle disorders.
Mol Genet Metab
; 139(3): 107609, 2023 07.
Article
in English
| MEDLINE | ID: mdl-37245377
2.
Evaluation of neurocognitive function of prefrontal cortex in ornithine transcarbamylase deficiency.
Mol Genet Metab
; 129(3): 207-212, 2020 03.
Article
in English
| MEDLINE | ID: mdl-31952925
3.
Choosing between medical management and liver transplant in urea cycle disorders: A conceptual framework for parental treatment decision-making in rare disease.
J Inherit Metab Dis
; 43(3): 438-458, 2020 05.
Article
in English
| MEDLINE | ID: mdl-31883128
4.
Self-reported treatment-associated symptoms among patients with urea cycle disorders participating in glycerol phenylbutyrate clinical trials.
Mol Genet Metab
; 116(1-2): 29-34, 2015.
Article
in English
| MEDLINE | ID: mdl-26296711
5.
The incidence of urea cycle disorders.
Mol Genet Metab
; 110(1-2): 179-80, 2013.
Article
in English
| MEDLINE | ID: mdl-23972786
6.
Hemodynamics of Prefrontal Cortex in Ornithine Transcarbamylase Deficiency: A Twin Case Study.
Front Neurol
; 11: 809, 2020.
Article
in English
| MEDLINE | ID: mdl-32922350
7.
Barriers to drug adherence in the treatment of urea cycle disorders: Assessment of patient, caregiver and provider perspectives.
Mol Genet Metab Rep
; 8: 43-7, 2016 Sep.
Article
in English
| MEDLINE | ID: mdl-27493880
8.
Protein and calorie intakes in adult and pediatric subjects with urea cycle disorders participating in clinical trials of glycerol phenylbutyrate.
Mol Genet Metab Rep
; 6: 34-40, 2016 Mar.
Article
in English
| MEDLINE | ID: mdl-27014577
Results
1 -
8
de 8
1
Next >
>>